Mid-dose losartan mitigates diabetes-induced hepatic damage by regulating iNOS, eNOS, VEGF, and NF- κB expressions
Conclusion: This study indicated that mid-dose losartan administration may have a therapeutic effect by inhibiting apoptosis and regulating iNOS, eNOS, VEGF, and NF-κB protein expressions in DM-induced hepatic damage.
PMID: 31652041 [PubMed - in process]
Source: Turkish Journal of Medical Sciences - Category: General Medicine Tags: Turk J Med Sci Source Type: research
More News: Cozaar | Diabetes | Diabetes Mellitus | Endocrinology | General Medicine | Hypertension | Liver | Losartan | Study | Turkey Health | Urology & Nephrology